Home

Ország generáció Email he4 ovarian cancer marker csináljuk Erkölcsi Testvériség

Reference ranges for HE4 and CA125 in a large Asian population by automated  assays and diagnostic performances for ovarian cancer - Park - 2012 -  International Journal of Cancer - Wiley Online Library
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library

JGO :: Journal of Gynecologic Oncology
JGO :: Journal of Gynecologic Oncology

HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of  Breast Cancer Progression
HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression

HE4 is overexpressed and secreted as a glycoprotein by ovarian... |  Download Scientific Diagram
HE4 is overexpressed and secreted as a glycoprotein by ovarian... | Download Scientific Diagram

HE4 in ovarian and uterine cancer » Professor Andreas Obermair
HE4 in ovarian and uterine cancer » Professor Andreas Obermair

Performance of preoperative plasma tumor markers HE4 and CA125 in  predicting ovarian cancer mortality in women with epithelial ovarian cancer  | PLOS ONE
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE

Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian  Cancer? | Bentham Science
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian  cancer
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer

Biomarkers in ovarian cancer and saliva: An update - Journal of  Reproductive Healthcare and Medicine
Biomarkers in ovarian cancer and saliva: An update - Journal of Reproductive Healthcare and Medicine

Electrochemical immunomagnetic assay as biosensing strategy for  determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect

PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125  and ROMA algorithm in patients with gynaecological diseases | Jose Miguel  Escudero - Academia.edu
PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor  Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,  - ppt video online download
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download

HE4: A Novel Serum Biomarker for Monitoring and Managing Epithelial Ovarian  Cancer
HE4: A Novel Serum Biomarker for Monitoring and Managing Epithelial Ovarian Cancer

Learn About HE4 - A Biomarker of Cancers in Women - Mindray Global
Learn About HE4 - A Biomarker of Cancers in Women - Mindray Global

A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and  risk malignancy index (RMI) for the classification of ovarian masses |  Clinics
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and  ROMA algorithm in patients with gynaecological diseases | Tumor Biology
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Tumor Biology

Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian  cancer and assessment of treatment response | Diagnostic Pathology | Full  Text
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text

WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer
WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer

Ovarian Cancer | Proteintech Group
Ovarian Cancer | Proteintech Group

Ovarian masses: Surgery or surveillance? | MDedge ObGyn
Ovarian masses: Surgery or surveillance? | MDedge ObGyn

OncoOVARIAN Dx – Ovarian Cancer Diagnosis Test – Bioprognos
OncoOVARIAN Dx – Ovarian Cancer Diagnosis Test – Bioprognos

Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human  Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer

Reference ranges of HE4 and CA125 according to age group | Download Table
Reference ranges of HE4 and CA125 according to age group | Download Table

A label-free dual immunosensor for the simultaneous electrochemical  determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian  cancer | SpringerLink
A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink

Diagnosis of ovarian epithelial cancer by performing a HE4 test
Diagnosis of ovarian epithelial cancer by performing a HE4 test

Table 2 from Determination of the Reference Values of the Tumor Marker HE4  in Female Population of Canton Sarajevo | Semantic Scholar
Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar

Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian  Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration  during Second- and Third-Line Chemotherapy
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy